CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline

Idiopathic pulmonary fibrosis presents a progressive and heterogeneous functional decline. CA 19-9 has been proposed as biomarker to predict disease course, but its role remains unclear. We assessed CA 19-9 levels and clinical data in end-stage ILD patients (48 IPF and 20 non-IPF ILD) evaluated for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Chron Respir Dis
Autors principals: Balestro, Elisabetta, Castelli, Gioele, Bernardinello, Nicol, Cocconcelli, Elisabetta, Biondini, Davide, Fracasso, Federico, Rea, Federico, Saetta, Marina, Baraldo, Simonetta, Spagnolo, Paolo
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7521048/
https://ncbi.nlm.nih.gov/pubmed/32969271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479973120958428
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars